Clinical Trial Update: Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating a pterygopalatine fossa block for aneurysmal subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Subarachnoid Hemorrhage, Aneurysmal | EARLY_Phase 1 | Status: COMPLETED